Invention Grant
- Patent Title: Biomarker DLEC1 for cancer
-
Application No.: US16530416Application Date: 2019-08-02
-
Publication No.: US11746383B2Publication Date: 2023-09-05
- Inventor: Qian Tao , Lili Li
- Applicant: The Chinese University of Hong Kong
- Applicant Address: CN Hong Kong
- Assignee: The Chinese University of Hong Kong
- Current Assignee: The Chinese University of Hong Kong
- Current Assignee Address: CN Hong Kong
- Agency: Kilpatrick Townsend & Stockton LLP
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12Q1/6886 ; C12Q1/6806 ; C12N5/09 ; C12N15/11

Abstract:
The present invention provides a method for diagnosing and determining prognosis of certain cancers (e.g., esophageal squamous cell carcinoma or ESCC) in a subject by detecting suppressed expression of the DLEC1 gene, which in some cases is due to elevated methylation level in the genomic sequence of this gene. A kit and device useful for such a method are also provided. In addition, the present invention provides a method for treating cancer by increasing DLEC1 gene expression or activity.
Information query